AU Patent
AU2014337314B2 — Compositions useful for treating disorders related to KIT
Assigned to Blueprint Medicines Corp · Expires 2018-12-13 · 7y expired
What this patent protects
Compounds and compositions useful for treating disorders related to mutant KIT are described herein.
USPTO Abstract
Compounds and compositions useful for treating disorders related to mutant KIT are described herein.
Drugs covered by this patent
- Ayvakit (AVAPRITINIB) · Blueprint Medicines
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.